Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Capital Expenditures (2019)

Traws Pharma (TRAW) has disclosed Capital Expenditures for 4 consecutive years, with -$1000.0 as the latest value for Q4 2019.

  • On a quarterly basis, Capital Expenditures changed N/A to -$1000.0 in Q4 2019 year-over-year; TTM through Dec 2023 was -$1000.0, a N/A change, with the full-year FY2024 number at $3.6 million, up 25957.14% from a year prior.
  • Capital Expenditures was -$1000.0 for Q4 2019 at Traws Pharma, down from $6000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of -$1000.0 in Q4 2019 to a low of -$1000.0 in Q4 2019.